Target intelligence / Profile preview

NRXN3 antisense RNA 2 (NRXN3-AS2)

Target
NRXN3-AS2
Molecular classification
Other (Long non-coding RNA, lncRNA)
01

Overview

NRXN3 antisense RNA 2 (NRXN3-AS2) is a long non-coding RNA (lncRNA) transcribed in the antisense orientation to the NRXN3 (Neurexin 3) gene locus. Like many antisense RNAs, it does not code for a protein, but may regulate the expression or splicing of the associated NRXN3 gene, which encodes an important synaptic cell adhesion protein involved in neurotransmission. While the precise biological functions of NRXN3-AS2 are not fully elucidated, it may play a role in neural gene regulation through transcriptional and post-transcriptional mechanisms. There are no reported drugs, biomarker uses, or established roles as a therapeutic target for NRXN3-AS2 itself. Important context: NRXN3-AS2 is distinct from Neurexin 3 (NRXN3), which is a synaptic cell surface receptor and active drug and disease target. NRXN3 itself is involved in synaptic organization and is associated with disorders such as autism and addiction. As an ncRNA, NRXN3-AS2 should not be confused with protein-coding targets, enzymes, or classical receptors. There is no evidence that NRXN3-AS2 is a direct disease biomarker, therapeutic target, or pharmacological receptor. If you intended information about the protein-coding Neurexin 3 (NRXN3), which is a recognized therapeutic target, please clarify. Otherwise, by strict naming, NRXN3-AS2 refers to the non-coding antisense RNA.

Other names
NRXN3-AS2NRXN3 antisense RNA 2
02

Biological functions

Regulation of gene expression (putative); may modulate NRXN3 gene expression
03

Disease associations

Other (Possible implication in neurodevelopmental and psychiatric processes, as related to regulation of NRXN3, but no direct, established disease association)

Beyond the preview

Go deeper on NRXN3 antisense RNA 2 (NRXN3-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NRXN3 antisense RNA 2 (NRXN3-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call